-
Retrieved 10
August 2022.
Sager JE, Lutz JD, Foti RS,
Davis C,
Kunze KL,
Isoherranen N (June 2014). "Fluoxetine- and norfluoxetine-mediated
complex drug-drug...
-
Characteristics (SmPC)". (emc). 1
February 2018.
Retrieved 15 May 2020.
Isoherranen N,
Kunze KL,
Allen KE,
Nelson WL,
Thummel KE (October 2004). "Role of...
- Biology. 8 (1): 6. doi:10.3390/jdb8010006. PMC 7151129. PMID 32151018.
Isoherranen N,
Zhong G (December 2019). "Biochemical and
physiological importance...
- PMID 22851683. S2CID 23689175.
Shirasaka Y,
Sager JE, Lutz JD,
Davis C,
Isoherranen N (July 2013). "Inhibition of CYP2C19 and CYP3A4 by
omeprazole metabolites...
- abm4054. hdl:10044/1/101589. PMID 36542696.
Nelson CH,
Buttrick BR,
Isoherranen N (2013). "Therapeutic
potential of the
inhibition of the
retinoic acid...
-
which [(2S,3S]-valnoctamide) was
considered to be a good
candidate by
Isoherranen, et al. for an
anticonvulsant in
August 2003.
Butabarbital can be hydrolyzed...
- 042. PMC 7194250. PMID 32169218.
Amory JK,
Muller CH,
Shimshoni JA,
Isoherranen N, Paik J,
Moreb JS, et al. (2011-01-01). "Suppression of ****togenesis...
- PMID 7482685. S2CID 1979283.
Sager JE, Lutz JD, Foti RS,
Davis C,
Kunze KL,
Isoherranen N (June 2014). "Fluoxetine- and norfluoxetine-mediated
complex drug-drug...
- Sciences. 18 (7): 601–610. PMC 3897029. PMID 24516494.
VandenBrink BM,
Isoherranen N (January 2010). "The role of
metabolites in
predicting drug-drug interactions:...
- 789–790. doi:10.1128/JB.94.3.789-790.1967. PMC 251956. PMID 4962848.
Isoherranen N, Lavy E,
Soback S (June 2000). "Pharmacokinetics of
gentamicin C(1)...
